ONPH is exploring strategic partnerships and opportunities in oncology

Our Portfolio (Licences - LOI)

Nanosmart Pharmaceuticals  -  
NanoSmart's® platform technology  (US  Patent No: 7,799,327 and EU 1706145 B1)


Connect2Med
Social engagement and retention platform for clinical trials


Sybleu, Inc.
Cancer therapy by intratumoral injection of a chemotherapeutic agent in combination with a bioactive immunostimulatory agent.  

Regen
Small Molecule Check Point NR2F6

Antigen Specific mRNA Cellular Cancer Vaccines
 

Licences